GS
Gilead Sciences Portfolio holdings
AUM
$1.28B
1 Year Est. Return
–
AUM
$1.28B
AUM Growth
+$98.9M
(+8.4%)
Holding
14
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Galapagos
GLPG
$2.09B
| $468M | 36.53% |
16,707,477
|
|
||
2
Arcellx
ACLX
$5.01B
| $443M | 34.57% |
6,720,803
|
|
||
3
Arcus Biosciences
RCUS
$2.1B
| $256M | 19.98% |
31,424,760
|
|
||
4
Assembly Biosciences
ASMB
$483M
| $40M | 3.13% |
2,209,471
|
|
||
5
Tango Therapeutics
TNGX
$1.07B
| $24.9M | 1.94% |
4,854,443
|
|
||
6
Merus
MRUS
$7.19B
| $23.8M | 1.86% |
452,527
|
|
||
7
Kyverna Therapeutics
KYTX
$301M
| $12.7M | 0.99% |
4,126,119
|
|
||
8
Xilio Therapeutics
XLO
$41.3M
| $6.19M | 0.48% |
9,105,451
|
|
||
|
HOOK
9
DELISTED
HOOKIPA Pharma
HOOK
| $2.35M | 0.18% |
1,875,945
|
|
||
10
Leap Therapeutics
LPTX
$25.3M
| $1.58M | 0.12% |
5,319,148
|
|
||
11
Allogene Therapeutics
ALLO
$275M
| $1.31M | 0.1% |
1,156,689
|
|
||
|
KLRS
12
Kalaris Therapeutics
KLRS
$94.1M
| $848K | 0.07% |
317,789
-405,484
|
|
||
|
IMA
13
ImageneBio Inc
IMA
$97.4M
| $467K | 0.04% |
29,045
-67,550
|
|
||
|
BRNS
14
Barinthus Biotherapeutics
BRNS
$53.9M
| $92.5K | 0.01% |
99,478
-270,377
|
|